News and information from Rex Bionics.
Chartered Society of Physiotherapists in UK encourages participants in RAPPER IV MS Trial
People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device. Read more…
MS Clinical Trials continue in UK
MS Clinical Trial starting at East Kent
Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used by people who have suffered a [...]
Research trial for Multiple Sclerosis and REX
Research team AIN-Rehab in collaboration with The University of Newcastle, Australia now has ethics approval to expand the HELLEN research trial using REX to include people living with Multiple Sclerosis. AIN-Rehab continue to work towards the goal [...]
REX at Armana Healthcare
Carina Botes of Armana Heathcare talks about her daily routine and using the REX device with patients. Amana Gulf News Rex DHA
REX initiates RAPPER III: Clinical Trial in Multiple Sclerosis
Ethics Committee Approval from NHS’s National Institute for Health Research (NIHR) Partnership with East Kent Hospitals University NHS Foundation Trust, and Kent University Rex Bionics Plc (AIM: RXB), is pleased to announce that the ethics [...]
REX in the Media
News and information about Rex Bionics in the media. These are external links and will take you away from the REX website.